The expression of RFX2 is negative in NSCLC and its subtypes’ datasets but positive in the SCLC dataset, which suggests its function could be that of a tumor suppressor in NSCLC and that of an oncogene in SCLC. The gene discussed is RFX2; the disease is small cell lung carcinoma.